PXD014683

PXD014683 is an original dataset announced via ProteomeXchange.

Title	Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry
Description	Purpose: Serum markers that enable diagnosis in the early stage of lung cancer have not been discovered. We have developed a LC-MRM-MS assay for the identification of potential early marker proteins for lung adenocarcinoma. Experimental design: LC-MRM-MS assay was used for measuring the level of 35 candidate peptides in plasma from 102 lung adenocarcinoma patients (including n=50, 16, 24, and 12 in stage I, II, III, and IV, respectively.) and 84 healthy controls. Stable isotope labeled standard peptides were synthesized to accurately measure the amount of these proteins. Results: Seven proteins were found to be able to distinguish stage I patients from controls. These proteins were combined in to a protein marker panel which improved the sensitivity to discriminate stage I patients from controls and resulted in a high classification performance with cross-validated area under the curve=0.76. Besides, we found that low expression of eukaryotic initiation factor 4A-I and high expression of lumican showed significantly poor prognosis in overall survival (p=0.012 and 0.0074, respectively), which may be used as prognostic biomarkers for lung cancer. Conclusion and clinical relevance: Proteins highlighted here may be used for early detection of lung adenocarcinoma or therapeutics development after validation in a larger cohort.
HostingRepository	PanoramaPublic
AnnounceDate	2021-01-24
AnnouncementXML	Submission_2021-01-24_16:59:16.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Supported dataset by repository
PrimarySubmitter	Hsin-Yi Wu
SpeciesList	scientific name: Homo sapiens; NCBI TaxID: 9606;
ModificationList	Label:13C(6)15N(2); Label:13C(6)15N(4)
Instrument	6495A Triple Quadrupole LC/MS

Revision	Datetime	Status	ChangeLog Entry
0	2019-07-19 10:56:14	ID requested
⏵ 1	2021-01-24 16:59:17	announced

Wu HY, Pan YY, Kopylov AT, Zgoda V, Ma MC, Wang CH, Su WC, Lai WW, Cheng PN, Liao PC, Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry. Proteomics Clin Appl, 14(4):e1900095(2020) [pubmed]

submitter keyword: early biomarkers, lung adenocarcinoma, LC-MRM-MS, plasma

Hsin-Yi Wu
contact affiliation	Instrumentation Center, National Taiwan University, Taipei 106, Taiwan
contact email	clairewu.wu@gmail.com
lab head
Hsin-Yi Wu
contact affiliation	Instrumentation Center, National Taiwan University, Taipei 106, Taiwan
contact email	clairewu.wu@gmail.com
dataset submitter

Panorama Public dataset URI